Status:
UNKNOWN
Effect of the Administration of L-Carnitine on Body Weight in Women in Crossfit Training
Lead Sponsor:
University of Guadalajara
Conditions:
Body Weight Changes
Eligibility:
FEMALE
18-40 years
Phase:
PHASE2
Brief Summary
The L-carnitine has demonstrated effects in the treatment of obesity mainly promoting the fat degradation during exercise.
Detailed Description
A randomized, double-blind, placebo-controlled clinical trial will be carry out in 24 woman with body mass index ≥ 25 to 29.9 kg/m2. The patients will receive 1.5 g of L-Carnitine deluded in 250 ml of...
Eligibility Criteria
Inclusion
- Volunteers who practice crossfit regularly (who have 3 months prior to the beginning of the study practicing crossfit).
- Volunteers with a body mass index equal to or greater than 25 Kg/m2.
- Volunteers who do not have allergies to L-Carnitine or any of its components.
- Informed consent signed
- Women with a recommendation of nutrition two weeks prior to the start of the study.
- Body weight stable the last 3 months.
Exclusion
- Volunteers with pathologies such as diabetes, hypertension, metabolic syndrome and allergies.
- Women with confirmed or suspected pregnancy.
- Women under lactation and/or puerperium.
- Hypersensibilility to L-Carnitine or Sucralose.
- Kown of renal, hepatic or thyroid deseased.
- Current or previous treatment diet (3 months before inclusion to the study).
- Current pharmacological treatment for loose body weight or 3 months before inclusion to the study.
Key Trial Info
Start Date :
December 17 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2019
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT03436277
Start Date
December 17 2018
End Date
May 1 2019
Last Update
February 20 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centro Universitario de Tonalá
Tonalá, Jalisco, Mexico, 45425